WBA sells shares of Cencora for $400 million of proceeds
Walgreens Boots Alliance (WBA) today announced that it has sold shares of Cencora pursuant to a share repurchase by Cencora in the amount of approximately $400 million.
Pharmacy
New campaign from FIP aims to advocate for the pharmacy profession worldwide
“Think Health, Think Pharmacy” is a new global campaign launched today by the International Pharmaceutical Federation (FIP).
Learn Look Locate and Walgreens launch second collaborative webpage
TUCSON, Ariz, – Learn Look Locate (LLL), an educational breast cancer platform, proudly announces the launch of its second collaborative webpage with Walgreens, dedicated to breast cancer awareness.
Kerico warns of impending health care crisis as telemedicine declines
HOUSTON – Kerico, a leading non-emergency medical transportation (NEMT) company, today issued a warning about the looming health care crisis as telemedicine usage rapidly declines and the demand for transportation to medical appointments surges.
Alvotech and Dr. Reddy’s partner to commercialize biosimilar candidate to Prolia & Xgeva
Alvotech and Dr. Reddy’s Laboratories SA have entered into a license and supply agreement for the commercialization of AVT03, Alvotech’s biosimilar candidate to Prolia and Xgeva (denosumab). The collaboration combines Dr.
NACDS to Senate: Pharmacies have a vital role to play in supporting food is medicine access
the nation’s most accessible healthcare providers — have an important role to play when it comes to driving food is medicine initiatives, providing prevention and management services for chronic disease, and delivering total health and wellness solutions.
Octapharma USA names industry veteran Kelly Hearn VP of Commercial Development and Marketing
PARAMUS, N.J. – Octapharma USA has appointed pharmaceutical industry veteran Kelly Hearn as Vice President of Commercial Development & Marketing, assuming immediate leadership of the product marketing team as the company continues to grow its presence in the U.S. market.
NACDS Foundation sponsors 42nd Annual March of Dimes Gourmet Gala
On Wednesday, May 15, March of Dimes hosted its 42nd Annual March of Dimes Gourmet Gala at the National Building Museum in Washington, DC. The National Association of Chain Drug Stores Foundation (NACDS Foundation) returned for its eighth year as a Platinum Sponsor of the evening.
NACDS to Congress: Want to sustain rural healthcare? Here’s how.
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) is urging the U.S.
APhA announces results of 2024 board elections
Today the American Pharmacists Association (APhA) announced the election of Magaly Rodriguez de Bittner, PharmD, FNAP, FAPhA, of Pasadena, MD, as 2025–2026 APhA president-elect. Rodrigeuz de Bittner will succeed Randy P.
Camber adds rufinamide oral suspension to product family
Camber Pharmaceuticals announced the addition of rufinamide oral suspension to its product line. Following the launch of Rufinamide Tablets in 2021, this new addition completes the Rufinamide product family.
Research finds pharmacies are most cost-effective options for patients with minor ailmements
ARLINGTON, Va. – A newly released research project demonstrates that pharmacist-provided care can play a vital role in enhancing public access to effective healthcare options, especially among the most vulnerable Americans.
Kroger Health launches new senior-focused primary care in Atlanta
Kroger Health, the healthcare division of The Kroger Co.
Asembia intros new technology suite to enhance patient speed to therapy
Asembia has introduced a new technology solution designed to improve their services for patients enrolled in ASPN HUB Support Programs.
Outcomes study: Consumers overwhelmingly open to receiving new clinical services from pharmacists
The vast majority (86%) of consumers are open to receiving new clinical services in pharmacies beyond traditional prescription filling, according to a recent survey commissioned by Outcomes Operating, Inc., an industry expert for integrated pharmacy workflow and patient
Walgreens brand Naloxone available online and in stores in May
which retails for $34.99, a lower price than the comparable national brand product at Walgreens stores, can reverse an overdose from opioids. The product is currently available online and